[go: up one dir, main page]

WO2001018189A3 - Verfahren zur expression von exogenen sequenzen in säugerzellen - Google Patents

Verfahren zur expression von exogenen sequenzen in säugerzellen Download PDF

Info

Publication number
WO2001018189A3
WO2001018189A3 PCT/EP2000/008563 EP0008563W WO0118189A3 WO 2001018189 A3 WO2001018189 A3 WO 2001018189A3 EP 0008563 W EP0008563 W EP 0008563W WO 0118189 A3 WO0118189 A3 WO 0118189A3
Authority
WO
WIPO (PCT)
Prior art keywords
sequences
mammalian cells
relates
nucleus
expressing exogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/008563
Other languages
English (en)
French (fr)
Other versions
WO2001018189A9 (de
WO2001018189A2 (de
Inventor
Daniele Zink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU74158/00A priority Critical patent/AU7415800A/en
Publication of WO2001018189A2 publication Critical patent/WO2001018189A2/de
Publication of WO2001018189A3 publication Critical patent/WO2001018189A3/de
Anticipated expiration legal-status Critical
Publication of WO2001018189A9 publication Critical patent/WO2001018189A9/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Verfahren zur Expression exogener Sequenzen in Abhängigkeit von der funktionellen Architektur des Genoms im Kern von Säugerzellen. Die Erfindung betrifft insbesondere ein Verfahren zur Expression von transgenen und proviralen Sequenzen in Säugerzellen, wobei die Sequenzen gezielt im aktiven Kompartiment der Kerns des Säugerzellen lokalisiert werden. Die Erfindung betrifft auch ein Verfahren zur Expression von exogenen Sequenzen in Säugerzellen, bei dem die Sequenzen gezielt in DNA des inaktiven Kompartiments des Kerns der Säugerzellen integriert werden. Weiter betrifft die Erfindung Verfahren zur Identifizierung von regulatorischen oder anderen Sequenzen, die eine stabile Lokalisation bzw. Integration zu exprimierender Sequenzen in aktiven Kompartimenten des Kerns einer Säugerzelle fördern. Die Erfindung betrifft weiterhin die Verwendung des erfindungsgemäßen Verfahrens in der Erzeugung transgener Tiere, zur Erzeugung von Geweben und Organen für Zwecke der Transplantation sowie den Einsatz des erfindungsgemäßen Verfahrens in der Gentherapie.
PCT/EP2000/008563 1999-09-03 2000-09-01 Verfahren zur expression von exogenen sequenzen in säugerzellen Ceased WO2001018189A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU74158/00A AU7415800A (en) 1999-09-03 2000-09-01 Method for expressing exogenous sequences in mammalian cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942149.8 1999-09-03
DE1999142149 DE19942149A1 (de) 1999-09-03 1999-09-03 Verfahren zur Expression von exogenen Sequenzen in Säugerzellen

Publications (3)

Publication Number Publication Date
WO2001018189A2 WO2001018189A2 (de) 2001-03-15
WO2001018189A3 true WO2001018189A3 (de) 2001-09-27
WO2001018189A9 WO2001018189A9 (de) 2002-09-06

Family

ID=7920733

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/008563 Ceased WO2001018189A2 (de) 1999-09-03 2000-09-01 Verfahren zur expression von exogenen sequenzen in säugerzellen

Country Status (3)

Country Link
AU (1) AU7415800A (de)
DE (1) DE19942149A1 (de)
WO (1) WO2001018189A2 (de)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001800A1 (en) * 1990-07-20 1992-02-06 Chiron Corporation Method for integrative transformation of yeast using dispersed repetitive elements
EP0592836A1 (de) * 1992-09-17 1994-04-20 American Cyanamid Company DNS der Integrationsstelle des menschlichen Adenassoziierten Virus und seine Verwendung
WO1994013273A1 (en) * 1992-12-08 1994-06-23 The Trustees Of The University Of Pennsylvania Sequences useful for obtaining high level, copy number-dependent, essentially position-independent gene expression in cellular and transgenic systems
WO1995033841A1 (en) * 1994-06-09 1995-12-14 Medical Research Council Locus control subregions for integration-site independent transgene expression
WO1996019573A1 (en) * 1994-12-19 1996-06-27 Cangene Corporation Recombinant dna molecules and expression vectors for erythropoietin
WO1997040183A2 (en) * 1996-04-10 1997-10-30 The Biological Research Center Of The Hungarian Academy Of Sciences Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
WO1997046691A1 (en) * 1996-06-03 1997-12-11 Universite Laval Integration cassette for improvement of transgenesis in eukaryotes
WO1997046687A1 (en) * 1996-06-06 1997-12-11 Novartis Ag Vectors comprising sar elements
WO1998007876A2 (en) * 1996-08-16 1998-02-26 Medical Research Council Self-replicating episomal expression vectors conferring tissue-specific gene expression
WO2000077176A1 (en) * 1999-06-14 2000-12-21 North Carolina State University Method for obtaining low copy transgenes by direct dna transformation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622084D0 (en) * 1996-10-23 1996-12-18 Isis Innovation Transinduction
US6245974B1 (en) * 1997-08-06 2001-06-12 North Carolina State University Matrix attachment regions

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001800A1 (en) * 1990-07-20 1992-02-06 Chiron Corporation Method for integrative transformation of yeast using dispersed repetitive elements
EP0592836A1 (de) * 1992-09-17 1994-04-20 American Cyanamid Company DNS der Integrationsstelle des menschlichen Adenassoziierten Virus und seine Verwendung
WO1994013273A1 (en) * 1992-12-08 1994-06-23 The Trustees Of The University Of Pennsylvania Sequences useful for obtaining high level, copy number-dependent, essentially position-independent gene expression in cellular and transgenic systems
WO1995033841A1 (en) * 1994-06-09 1995-12-14 Medical Research Council Locus control subregions for integration-site independent transgene expression
WO1996019573A1 (en) * 1994-12-19 1996-06-27 Cangene Corporation Recombinant dna molecules and expression vectors for erythropoietin
WO1997040183A2 (en) * 1996-04-10 1997-10-30 The Biological Research Center Of The Hungarian Academy Of Sciences Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
WO1997046691A1 (en) * 1996-06-03 1997-12-11 Universite Laval Integration cassette for improvement of transgenesis in eukaryotes
WO1997046687A1 (en) * 1996-06-06 1997-12-11 Novartis Ag Vectors comprising sar elements
WO1998007876A2 (en) * 1996-08-16 1998-02-26 Medical Research Council Self-replicating episomal expression vectors conferring tissue-specific gene expression
WO2000077176A1 (en) * 1999-06-14 2000-12-21 North Carolina State University Method for obtaining low copy transgenes by direct dna transformation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BROWN K ET AL: "Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin", CELL, vol. 91, no. 6, 12 December 1997 (1997-12-12), pages 845 - 854, XP002162572 *
MCKNIGHT R ET AL: "Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., vol. 89, no. 15, 1 August 1992 (1992-08-01), pages 6943 - 6947, XP002162570 *
MCKNIGHT R ET AL: "Severe position effects imposed on a 1 kb mouse whey acidic protein gene promoter are overcome by heterologous matrix attachment regions", MOL REPROD DEV., vol. 44, no. 2, June 1996 (1996-06-01), pages 179 - 184, XP002162569 *
SADONI N ET AL: "Nuclear organization of mammalian genomes. Polar chromosome territories build up functionally distinct higher order compartments", THE JOURNAL OF CELL BIOLOGY., vol. 146, no. 6, 20 September 1999 (1999-09-20), pages 1211 - 1226, XP002162571 *

Also Published As

Publication number Publication date
WO2001018189A9 (de) 2002-09-06
AU7415800A (en) 2001-04-10
DE19942149A1 (de) 2001-03-15
WO2001018189A2 (de) 2001-03-15

Similar Documents

Publication Publication Date Title
Inoue et al. Effects of donor cell type and genotype on the efficiency of mouse somatic cell cloning
Alexander et al. Liposome-mediated gene transfer and expression via the skin
EP2465921A3 (de) Herzstammzellen aus der Biopsie
DE69906977D1 (de) In liposomen verkapselte nukleinsäurekomplexe
WO1997040183A3 (en) Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
Hohenstein et al. High-efficiency Rosa26 knock-in vector construction for Cre-regulated overexpression and RNAi
BR0015148A (pt) Produção androgenética ou ginogenética de linhas de células e células pluripotentes, e seu uso para produzir tecidos e células diferenciados
WO2001096532A3 (en) Method of generating pluripotent mammalian cells by fusion of a cytoplast fragment with a karyoplast
WO2000073478A3 (en) Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
WO1997042975A3 (en) Chitosan related compositions for delivery of nucleic acids into a cell
WO2003027278A1 (en) Tailor-made multifunctional stem cells and utilization thereof
WO2003000114A3 (en) Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
IL148152A0 (en) Sequence-specific dna recombination in eukaryotic cells
WO2004108904A3 (en) Porcine cmp-n-acetylneuraminic acid hydroxylase gene
WO2007064846A3 (en) COMPOSITIONS AND METHODS OF USING siRNA TO KNOCKDOWN GENE EXPRESSION AND TO IMPROVE SOLID ORGAN AND CELL TRANSPLANTATION
CN108642054A (zh) 降低免疫原性sgRNA、低免疫原性敷料及其制备方法
WO2004007749A3 (en) Methods and systems for extended in vitro culture of neuronal cells
WO2005047469A3 (en) PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
WO2006065960A3 (en) Cationic liposomes comprising a charge neutral compound and a cationic phospholipid
ATE312935T1 (de) Regulatorische sequenzen für die in-vivo- expression einer heterologen dns-sequenz in endothelzellen und ihre verwendungen.
ATE524198T1 (de) Verfahren zur einführung von genen in säugetiere
WO2005111204A3 (en) Porcine forssman synthetase cdna and polypeptide
WO2001018189A3 (de) Verfahren zur expression von exogenen sequenzen in säugerzellen
CA2358040A1 (en) Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane
WO2001002020A3 (en) Compositions and methods for targeted enzymatic release of cell regulatory compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

COP Corrected version of pamphlet

Free format text: PAGES 1/6-6/6, DRAWINGS, REPLACED BY NEW PAGES 1/6-6/6; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP